Menu
Search
|

Menu

Close
X

Alliqua BioMedical Inc ALQA.OQ (NASDAQ Stock Exchange Capital Market)

1.73 USD
+0.01 (+0.58%)
As of Feb 16
chart
Previous Close 1.72
Open 1.71
Volume 2,343
3m Avg Volume 15,233
Today’s High 1.81
Today’s Low 1.71
52 Week High 8.47
52 Week Low 1.59
Shares Outstanding (mil) 5.01
Market Capitalization (mil) 14.53
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY17
15
FY16
18
FY15
12
EPS (USD)
FY17
-4.161
FY16
-11.582
FY15
-11.321
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
0.73
5.77
Price to Book (MRQ)
vs sector
0.50
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
41.03
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
-73.36
14.43
Return on Equity (TTM)
vs sector
-86.70
16.13

EXECUTIVE LEADERSHIP

David Johnson
President, Chief Executive Officer, Director, Since 2013
Salary: $350,000.00
Bonus: $245,000.00
Brian Posner
Chief Financial Officer, Treasurer, Secretary, Since 2013
Salary: $240,000.00
Bonus: $100,800.00
Bradford Barton
Chief Operating Officer, Since 2014
Salary: $240,000.00
Bonus: $100,800.00
Nino Pionati
Chief Strategy & Marketing Officer, Since 2015
Salary: $240,000.00
Bonus: $100,800.00
Gary Restani
Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1010 Stony Hill Rd Ste 200
YARDLEY   PA   19067-5545

Phone: +1215.7028550
Site: alliqua.com

Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers SilverSeal.

SPONSORED STORIES